Dublin startup wins Seedcorn InterTradeIreland award
Valitacell’s technology reduces cost and time incurred by pharma firms in bringing drugs to market
Dr Terry McWade (left), chief executive of Valitacell and Conor Sweeney of InterTradeIreland. Photograph: Conor McCabe
Dublin-based startup Valitacell has won this year’s Seedcorn investor readiness award from InterTradeIreland. The biotech firm has developed technology that transforms both the speed and cost incurred by pharma firms in bringing biologic drugs to market.
Valitacell saw off stiff competition from several other new and early-stage finalists companies. Each of the eight finalists were regional winners, receiving €20,000. They were then entered into categories: new start companies under five years of age seeking equity of between €50,000 and €299,999; and early-stage companies under five years seeking in excess of €300,000.
Along with the overall prixe, Valitacell also won the early-stage category.